Search alternatives:
significant force » significant source (Expand Search), significant sources (Expand Search), significant concern (Expand Search)
marked decrease » marked increase (Expand Search)
force decrease » fold decrease (Expand Search), forces increased (Expand Search)
significant force » significant source (Expand Search), significant sources (Expand Search), significant concern (Expand Search)
marked decrease » marked increase (Expand Search)
force decrease » fold decrease (Expand Search), forces increased (Expand Search)
-
1
-
2
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
3
-
4
-
5
MiR-129-5p levels were decreased in mouse depression models.
Published 2025“…(n = 3 - 10 mice per group; Data are presented as the mean ± standard error; *, **, ***, and **** indicate significance at p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively.).…”
-
6
-
7
-
8
-
9
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
10
-
11
-
12
-
13
-
14
Altered expression of genes related to Ca<sup>2+</sup> cycling or myocardial contraction.
Published 2025Subjects: -
15
-
16
-
17
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
-
18
-
19
-
20